Stay updated with breaking news from Caredx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of CareDx, Inc (NASDAQ:CDNA – Get Free Report) have been assigned a consensus recommendation of “Hold” from the six research firms that are currently covering the stock, MarketBeat Ratings reports. Four analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12-month price […]
CareDx (NASDAQ:CDNA – Get Free Report) and Aclarion (NASDAQ:ACON – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, valuation, dividends and risk. Earnings and Valuation This table compares CareDx and Aclarion’s […]
Royce & Associates LP raised its holdings in CareDx, Inc (NASDAQ:CDNA – Free Report) by 332.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 432,505 shares of the company’s stock after purchasing an additional 332,400 shares during the quarter. Royce & Associates LP’s […]
BRISBANE, Calif., August 31, 2023--CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the Company will participate in the H.C. Wainwright 25th Annual Global Investment Conference.
StockNews.com started coverage on shares of CareDx (NASDAQ:CDNA – Free Report) in a research report sent to investors on Thursday. The brokerage issued a hold rating on the stock. A number of other analysts also recently issued reports on CDNA. BTIG Research downgraded shares of CareDx from a buy rating to a neutral rating in […]